zidovudine has been researched along with glycerol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Jeong, SY; Lee, JH; Oh, SY; Park, TG | 1 |
| Anderson, BD; Johnson, MD | 1 |
| Balzarini, J; Calogeropoulou, T; Daliani, I; De Clercq, E; Demetzos, C; Kolocouris, A; Koufaki, M; Makriyannis, A; Mavromoustakos, T; Meng, Z | 1 |
| Apte, SS; Gopinath, D; Rambhau, D; Rao, BR; Ravi, D | 1 |
| Ackermans, M; Blümer, RM; Danner, SA; Hassink, E; Reiss, P; Sauerwein, HP; Sutinen, J; van Agtmael, MA; van Vonderen, MG; Yki-Jarvinen, H | 1 |
1 trial(s) available for zidovudine and glycerol
| Article | Year |
|---|---|
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.
Topics: Adiponectin; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Glucose; Glycerol; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperinsulinism; Insulin Resistance; Lamivudine; Lipid Metabolism; Lipids; Lopinavir; Male; Middle Aged; Pyrimidinones; Time Factors; Treatment Outcome; Zidovudine | 2008 |
6 other study(ies) available for zidovudine and glycerol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer.
Topics: Administration, Cutaneous; Animals; Anti-HIV Agents; Buffers; Drug Delivery Systems; Female; Glycerol; Iontophoresis; Karaya Gum; Mice; Mice, Hairless; Oleic Acid; Propylene Glycol; Reverse Transcriptase Inhibitors; Skin Absorption; Zidovudine | 1998 |
In vitro models of the blood-brain barrier to polar permeants: comparison of transmonolayer flux measurements and cell uptake kinetics using cultured cerebral capillary endothelial cells.
Topics: Acetamides; Animals; Blood-Brain Barrier; Brain; Cattle; Cell Membrane Permeability; Cells, Cultured; Endothelium, Vascular; Glycerol; Mannitol; Models, Biological; Rats; Sucrose; Urea; Zidovudine | 1999 |
Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Calorimetry, Differential Scanning; Cells, Cultured; Dideoxynucleotides; Drug Screening Assays, Antitumor; Glycerol; HIV-1; HIV-2; Humans; Lipid Bilayers; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Molecular Conformation; Nucleosides; Solutions; T-Lymphocytes; Thymidine Kinase; Zidovudine | 2001 |
1-O-Alkylglycerol vesicles (Algosomes): their formation and characterization.
Topics: Biological Transport; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Glycerol; Osmosis; Photomicrography; Time Factors; Zidovudine | 2002 |